Nanorepro AG NNGRF:OTCPK

RT Quote | Exchange | USD
Last | 03/02/21 EST
22.71UNCH (UNCH)
Volume
2,130
52 week range
21.51 - 22.71

...

Loading . . .

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close22.71
  • 52 Week High22.71
  • 52 Week High Date03/02/21
  • 52 Week Low21.51
  • 52 Week Low Date03/02/21
  • Market Cap140.69M
  • Shares Out9.51M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)0.49
  • P/E (TTM)46.48
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Nanorepro AG News

There is no recent news for this security.

Latest NNGRF News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Nanorepro AG is a Germany-based company active in the biotechnology sector. The Company is engaged in the research of stem cells, which are used in the medical treatment due to their ability to self-renew and differentiate to a range of specialized cell types. Nanorepro AG gathers samples of patients’ stem cells and stores them for the future use. Its portfolio also comprises OTC rapid diagnostic tests, such as OvuQUICK, an ovulation test for women; GraviQUICK, a pregnancy...
Lisa Juengst
Chief Executive Officer
Michael Fuchs
Chief Financial Officer
Address
Untergasse 8
Marburg An Der Lahn
35037
Germany